Michael Exton, Ph.D.
CEO
Board Member
Executive changes
- 2024-07-08
-
Appointed chief executive officer (in which capacity he will function as our principal executive officer) at Lexicon Pharmaceuticals, Inc. (LXRX)2024-07-08
Earnings-call appearances
-
Lexicon Pharmaceuticals, Inc. Q2 FY2026 Earnings Call2026-08-06
Lexicon Pharmaceuticals, Inc. (LXRX)